Novel antisense and peptide nucleic acid strategies for controlling gene expression

Dwaine A. Braasch, David R. Corey

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

Antisense oligonucleotides have the potential to make revolutionary contributions to basic science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because they can be rapidly synthesized to be complementary to any sequence, they offer ideal tools for exploiting the massive amount of genome information now available. However, until recently, this potential was largely theoretical, and antisense experiments often produced inconclusive or misleading outcomes. This review will discuss the chemical and biological properties of some of the different types of oligomers now available and describe the challenges confronting in vitro and in vivo use of oligonucleotides. Oligomers with improved chemical properties, combined with advances in cell biology and success in clinical trials, are affording powerful new options for basic research, biotechnology, and medicine.

Original languageEnglish (US)
Pages (from-to)4503-4510
Number of pages8
JournalBiochemistry
Volume41
Issue number14
DOIs
StatePublished - Apr 9 2002

Fingerprint

Peptide Nucleic Acids
Oligomers
Gene expression
Oligonucleotides
Medicine
Cytology
Gene Expression
Antisense Oligonucleotides
Protein Biosynthesis
Biotechnology
Chemical properties
Cell Biology
Genes
Clinical Trials
Genome
Messenger RNA
Research
Experiments
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry

Cite this

Novel antisense and peptide nucleic acid strategies for controlling gene expression. / Braasch, Dwaine A.; Corey, David R.

In: Biochemistry, Vol. 41, No. 14, 09.04.2002, p. 4503-4510.

Research output: Contribution to journalArticle

@article{c4ef04482ac142e2a3eb30503811dd33,
title = "Novel antisense and peptide nucleic acid strategies for controlling gene expression",
abstract = "Antisense oligonucleotides have the potential to make revolutionary contributions to basic science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because they can be rapidly synthesized to be complementary to any sequence, they offer ideal tools for exploiting the massive amount of genome information now available. However, until recently, this potential was largely theoretical, and antisense experiments often produced inconclusive or misleading outcomes. This review will discuss the chemical and biological properties of some of the different types of oligomers now available and describe the challenges confronting in vitro and in vivo use of oligonucleotides. Oligomers with improved chemical properties, combined with advances in cell biology and success in clinical trials, are affording powerful new options for basic research, biotechnology, and medicine.",
author = "Braasch, {Dwaine A.} and Corey, {David R.}",
year = "2002",
month = "4",
day = "9",
doi = "10.1021/bi0122112",
language = "English (US)",
volume = "41",
pages = "4503--4510",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "14",

}

TY - JOUR

T1 - Novel antisense and peptide nucleic acid strategies for controlling gene expression

AU - Braasch, Dwaine A.

AU - Corey, David R.

PY - 2002/4/9

Y1 - 2002/4/9

N2 - Antisense oligonucleotides have the potential to make revolutionary contributions to basic science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because they can be rapidly synthesized to be complementary to any sequence, they offer ideal tools for exploiting the massive amount of genome information now available. However, until recently, this potential was largely theoretical, and antisense experiments often produced inconclusive or misleading outcomes. This review will discuss the chemical and biological properties of some of the different types of oligomers now available and describe the challenges confronting in vitro and in vivo use of oligonucleotides. Oligomers with improved chemical properties, combined with advances in cell biology and success in clinical trials, are affording powerful new options for basic research, biotechnology, and medicine.

AB - Antisense oligonucleotides have the potential to make revolutionary contributions to basic science and medicine. Oligonucleotides can bind mRNA and inhibit translation. Because they can be rapidly synthesized to be complementary to any sequence, they offer ideal tools for exploiting the massive amount of genome information now available. However, until recently, this potential was largely theoretical, and antisense experiments often produced inconclusive or misleading outcomes. This review will discuss the chemical and biological properties of some of the different types of oligomers now available and describe the challenges confronting in vitro and in vivo use of oligonucleotides. Oligomers with improved chemical properties, combined with advances in cell biology and success in clinical trials, are affording powerful new options for basic research, biotechnology, and medicine.

UR - http://www.scopus.com/inward/record.url?scp=0037046160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037046160&partnerID=8YFLogxK

U2 - 10.1021/bi0122112

DO - 10.1021/bi0122112

M3 - Article

C2 - 11926811

AN - SCOPUS:0037046160

VL - 41

SP - 4503

EP - 4510

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 14

ER -